Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Ginseng Res ; 43(4): 676-683, 2019 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-31695571

RESUMEN

BACKGROUND: Korean Red Ginseng (KRG) is widely used for strengthening the immune system and fighting fatigue, especially in people with deficiency syndrome. However, there is concern that the long-term application or a high dose of KRG can cause "fireness" ( in Chinese) because of its "dryness" ( in Chinese). The aim of this study was to assess the safety and efficacy of a 4-week treatment with KRG in participants with deficiency syndrome. METHODS: This was a 4-week, randomized, double-blind, placebo-controlled clinical trial. A total of 180 Chinese participants were randomly allocated to three groups: placebo control group, participants were given a placebo, 3.6 g/d; KRG 1.8 g and 3.6 g groups. The primary outcomes were the changes in fireness and safety evaluation (adverse events, laboratory tests, and electrocardiogram). The secondary outcomes were the efficacy of KRG on fatigue, which include the following: traditional Chinese medicine (TCM) symptom scale and fatigue self-assessment scale. RESULTS: Of the 180 patients, 174 completed the full study. After 4 weeks of KRG treatment, the Fire-heat symptoms score including Excess fire-heat score and Deficient fire-heat score showed no significant change as compared with placebo treatment, and no clinically significant changes in any safety parameter were observed. Based on the TCM syndrome score and fatigue self-assessment score, TCM symptoms and fatigue were greatly improved after treatment with KRG, which showed a dose- and time-dependent effect. The total effective rate was also significantly increased in the KRG groups. CONCLUSION: Our study revealed that KRG has a potent antifatigue effect without significant adverse effects in people with deficiency syndrome. Although a larger sample size and longer treatment may be required for a more definite conclusion, this clinical trial is the first to disprove the common conception of "fireness" related to KRG.

2.
Arch Pharm Res ; 27(9): 912-4, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15473659

RESUMEN

Seven compounds were isolated from the stem of Acanthopanax senticosus by repeated column chromatography. Their structures were elucidated as isovanillin (1), (-)-sesamin (2), isofraxidin (3), (+)-syringaresinol (4), 5-hydroxymethylfurfural (5), eleutheroside B (6), and eleutheroside E (7) by spectral analysis. Among them, isovanillin (1) was isolated for the first time from the family Araliaceae.


Asunto(s)
Benzaldehídos/química , Benzaldehídos/aislamiento & purificación , Benceno/química , Benceno/aislamiento & purificación , Eleutherococcus , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Tallos de la Planta
3.
Eur J Pharmacol ; 493(1-3): 99-102, 2004 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-15189769

RESUMEN

A poor supply of oxygen and glucose to the brain can cause severe brain damage. Therefore, neuroprotective drugs against ischemia need to be developed. In this study, wogonin, a flavone found in Scutellaria baicalensis, had a protective effect on neuronal cells damaged by oxygen and glucose deprivation in rat hippocampal slices in culture. In particular, the protective effect on the pyramidal cell layer was significant. On the basis of these experimental results, wogonin may be a therapeutic agent for treating ischemia in patients.


Asunto(s)
Flavanonas/farmacología , Fármacos Neuroprotectores/farmacología , Células Piramidales/efectos de los fármacos , Células Piramidales/patología , Animales , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Hipoxia de la Célula/efectos de los fármacos , Hipoxia de la Célula/fisiología , Evaluación Preclínica de Medicamentos/métodos , Flavanonas/uso terapéutico , Predicción , Glucosa/efectos adversos , Glucosa/deficiencia , Glucosa/fisiología , Corea (Geográfico) , Células Piramidales/ultraestructura , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Técnicas de Cultivo de Tejidos/métodos
4.
Arch Pharm Res ; 27(1): 106-10, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14969348

RESUMEN

The antioxidant activities of Acanthopanax senticosus stems were evaluated in CCl4-intoxicated rats. The n-butanol fraction from the water extract of the stems, when pretreated orally at 200 mg/kg/day for 7 consecutive days in rats, was demonstrated to exhibit significant increases in antioxidant enzyme activities such as hepatic cytosolic superoxide dismutase, catalase and glutathione peroxidase by 30.31, 19.82 and 155%, respectively. The n-butanol fraction whereas showed a significant inhibition of serum GPT activity (65.79% inhibition) elevated with hepatic damage induced by CCl4-intoxication. Eleutheroside B, a lignan component, isolated from the n-butanol fraction was found to cause a moderate free radical scavenging effect on DPPH, its scavenging potency as indicated in IC50 value, being 58.5 microM. These results suggested that the stems of A. senticosus possess not only antioxidant but also hepatoprotective activities.


Asunto(s)
Antioxidantes/farmacología , Eleutherococcus/química , Lignanos/farmacología , Tallos de la Planta/química , Administración Oral , Alanina Transaminasa/sangre , Alanina Transaminasa/efectos de los fármacos , Animales , Antioxidantes/química , Antioxidantes/aislamiento & purificación , Aspartato Aminotransferasas/sangre , Aspartato Aminotransferasas/efectos de los fármacos , Compuestos de Bifenilo , Butanoles/administración & dosificación , Butanoles/química , Butanoles/farmacocinética , Intoxicación por Tetracloruro de Carbono/tratamiento farmacológico , Intoxicación por Tetracloruro de Carbono/metabolismo , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Depuradores de Radicales Libres/metabolismo , Depuradores de Radicales Libres/farmacología , Glucósidos/administración & dosificación , Glucósidos/química , Glucósidos/farmacocinética , Hepatocitos/efectos de los fármacos , Hepatocitos/metabolismo , Hepatocitos/patología , Indicadores y Reactivos , Lignanos/química , Lignanos/aislamiento & purificación , Masculino , Fenilpropionatos/administración & dosificación , Fenilpropionatos/química , Fenilpropionatos/farmacocinética , Picratos/antagonistas & inhibidores , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Ratas , Ratas Sprague-Dawley , Silimarina/administración & dosificación , Silimarina/farmacocinética , Silimarina/uso terapéutico , Solubilidad , Agua/química
5.
Neurosci Lett ; 348(1): 51-5, 2003 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-12893423

RESUMEN

Uncaria rhynchophylla is a medicinal herb which has sedative and anticonvulsive effects and has been applied in the treatment of epilepsy in Oriental medicine. In this study, the effect of alkaloid fraction of U. rhynchophylla against N-methyl-D-aspartate (NMDA)-induced neuronal cell death was investigated. Pretreatment with an alkaloid fraction of U. rhynchophylla for 1 h decreased the degree of neuronal damage induced by NMDA exposure in cultured hippocampal slices and also inhibited NMDA-induced enhanced expressions of apoptosis-related genes such as c-jun, p53, and bax. In the present study, the alkaloid fraction of U. rhynchophylla was shown to have a protective property against NMDA-induced cytotoxicity by suppressing the NMDA-induced apoptosis in rat hippocampal slices.


Asunto(s)
Alcaloides/farmacología , Apoptosis , Hipocampo/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2 , Uncaria/química , Animales , Animales Recién Nacidos , Antisepsia/métodos , Ciclina D1/biosíntesis , Ciclina D1/genética , Maleato de Dizocilpina/farmacología , Interacciones Farmacológicas , Agonistas de Aminoácidos Excitadores/toxicidad , Antagonistas de Aminoácidos Excitadores/farmacología , Hipocampo/citología , Técnicas In Vitro , Indicadores y Reactivos/farmacocinética , N-Metilaspartato/toxicidad , Neuronas/efectos de los fármacos , Plantas Medicinales , Propidio/farmacocinética , Proteínas Proto-Oncogénicas/biosíntesis , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas c-jun/biosíntesis , Proteínas Proto-Oncogénicas c-jun/genética , ARN Mensajero/biosíntesis , Ratas , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Factores de Tiempo , Proteína p53 Supresora de Tumor/biosíntesis , Proteína p53 Supresora de Tumor/genética , Proteína X Asociada a bcl-2
6.
J Pharmacol Sci ; 92(1): 74-8, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12832858

RESUMEN

In the present work, we found that the ethyl acetate-soluble fraction of Cnidium officinale MAKINO (COEA) decreased nitric oxide (NO) production in the lipopolysaccharide (LPS)-stimulated BV-2 and primary microglia and suppressed expression of inducible nitric oxide synthase (iNOS) in BV-2 cells with the same pattern of NO production. In addition, we showed that excessive NO production played an important role in neuronal cell death in LPS-treated rat hippocampal slice cultures. Our data suggest that the COEA inhibits neuronal cell death by reduction of excessive NO production in LPS-treated rat hippocampal slice cultures. The ethyl acetate-soluble fraction of C. officinale reduced propidium iodide uptake and NO production in cultured media at the same time.


Asunto(s)
Cnidium/química , Hipocampo/efectos de los fármacos , Lipopolisacáridos/farmacología , Microglía/efectos de los fármacos , Neuronas/efectos de los fármacos , Óxido Nítrico/biosíntesis , Acetatos , Animales , Western Blotting , Muerte Celular/efectos de los fármacos , Supervivencia Celular , Hipocampo/citología , Técnicas In Vitro , Microglía/citología , Neuronas/citología , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa de Tipo II , Extractos Vegetales/farmacología , Raíces de Plantas/química , Ratas
7.
J Pharmacol Sci ; 92(1): 70-3, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12832857

RESUMEN

Uncaria rhynchophylla is a medicinal herb used for convulsive disorders in Oriental medicine. In this study, the effect of the methanol extract of Uncaria rhynchophylla against N-methyl-D-aspartate (NMDA)-induced excitotoxicity was investigated. Pretreatment with the extract of Uncaria rhynchopylla reduced the degree of neuronal damage induced by NMDA exposure in cultured hippocampal slices. In the patch clamp study, Uncaria rhynchophylla significantly inhibited NMDA receptor-activated ion current in acutely dissociated hippocampal CA1 neurons. These results indicate that Uncaria rhynchophylla offers protection against NMDA-induced neuronal injury and inhibitory action on NMDA receptor-mediated ion current may be a mechanism behind the neuroprotective effect of Uncaria rhynchophylla.


Asunto(s)
Hipocampo/efectos de los fármacos , N-Metilaspartato/metabolismo , Fármacos Neuroprotectores/farmacología , Neurotoxinas/metabolismo , Uncaria/química , Animales , Hipocampo/patología , Técnicas In Vitro , Canales Iónicos/efectos de los fármacos , Canales Iónicos/metabolismo , Metanol , N-Metilaspartato/toxicidad , Neurotoxinas/toxicidad , Técnicas de Placa-Clamp , Extractos Vegetales/farmacología , Propidio/metabolismo , Ratas , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA